These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

648 related items for PubMed ID: 17559369

  • 1. Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome.
    Chang FY, Lu CL, Chen CY, Luo JC.
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2266-72. PubMed ID: 17559369
    [Abstract] [Full Text] [Related]

  • 2. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P, Dapoigny M, Bonaz B, Siproudhis L.
    Aliment Pharmacol Ther; 2005 Feb 15; 21(4):435-44. PubMed ID: 15709995
    [Abstract] [Full Text] [Related]

  • 3. A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.
    Chang L, Ameen VZ, Dukes GE, McSorley DJ, Carter EG, Mayer EA.
    Am J Gastroenterol; 2005 Jan 15; 100(1):115-23. PubMed ID: 15654790
    [Abstract] [Full Text] [Related]

  • 4. Octatropine methyl bromide and diazepam combination (Valpinax) in patients with irritable bowel syndrome: a multicentre, randomized, placebo-controlled trial.
    Pace F, Maurano A, Ciacci C, Savarino V, Attili A, Iaquinto G, Magni E, Porro GB.
    Eur Rev Med Pharmacol Sci; 2010 Mar 15; 14(3):155-62. PubMed ID: 20391952
    [Abstract] [Full Text] [Related]

  • 5. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial.
    Leung WK, Wu JC, Liang SM, Chan LS, Chan FK, Xie H, Fung SS, Hui AJ, Wong VW, Che CT, Sung JJ.
    Am J Gastroenterol; 2006 Jul 15; 101(7):1574-80. PubMed ID: 16863563
    [Abstract] [Full Text] [Related]

  • 6. A randomized, double-blind, placebo-controlled study to assess efficacy and safety of 0.5 mg and 1 mg alosetron in women with severe diarrhea-predominant IBS.
    Krause R, Ameen V, Gordon SH, West M, Heath AT, Perschy T, Carter EG.
    Am J Gastroenterol; 2007 Aug 15; 102(8):1709-19. PubMed ID: 17509028
    [Abstract] [Full Text] [Related]

  • 7. Randomised clinical trial: the clinical effects of a novel neurokinin receptor antagonist, DNK333, in women with diarrhoea-predominant irritable bowel syndrome.
    Zakko S, Barton G, Weber E, Dunger-Baldauf C, Rühl A.
    Aliment Pharmacol Ther; 2011 Jun 15; 33(12):1311-21. PubMed ID: 21507028
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical trial: the efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome--a randomized, double-blind, placebo-controlled study.
    Wittmann T, Paradowski L, Ducrotté P, Bueno L, Andro Delestrain MC.
    Aliment Pharmacol Ther; 2010 Mar 15; 31(6):615-24. PubMed ID: 20003095
    [Abstract] [Full Text] [Related]

  • 10. Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study.
    Tack JF, Miner PB, Fischer L, Harris MS.
    Aliment Pharmacol Ther; 2011 Oct 15; 34(8):868-77. PubMed ID: 21883322
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R, Nikfar S, Abdollahi M.
    Clin Ther; 2008 May 15; 30(5):884-901. PubMed ID: 18555935
    [Abstract] [Full Text] [Related]

  • 12. Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome.
    Leventer SM, Raudibaugh K, Frissora CL, Kassem N, Keogh JC, Phillips J, Mangel AW.
    Aliment Pharmacol Ther; 2008 Jan 15; 27(2):197-206. PubMed ID: 17973974
    [Abstract] [Full Text] [Related]

  • 13. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
    Dove LS, Lembo A, Randall CW, Fogel R, Andrae D, Davenport JM, McIntyre G, Almenoff JS, Covington PS.
    Gastroenterology; 2013 Aug 15; 145(2):329-38.e1. PubMed ID: 23583433
    [Abstract] [Full Text] [Related]

  • 14. Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome.
    Chey WD, Chey WY, Heath AT, Dukes GE, Carter EG, Northcutt A, Ameen VZ.
    Am J Gastroenterol; 2004 Nov 15; 99(11):2195-203. PubMed ID: 15555002
    [Abstract] [Full Text] [Related]

  • 15. Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome.
    Vahedi H, Merat S, Momtahen S, Kazzazi AS, Ghaffari N, Olfati G, Malekzadeh R.
    Aliment Pharmacol Ther; 2008 Apr 15; 27(8):678-84. PubMed ID: 18248658
    [Abstract] [Full Text] [Related]

  • 16. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P.
    Gastroenterol Clin Biol; 2008 Feb 15; 32(2):147-52. PubMed ID: 18387426
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome.
    Saito YA, Rey E, Almazar-Elder AE, Harmsen WS, Zinsmeister AR, Locke GR, Talley NJ.
    Am J Gastroenterol; 2010 Jan 15; 105(1):170-7. PubMed ID: 19809408
    [Abstract] [Full Text] [Related]

  • 20. Cisapride treatment of constipation-predominant irritable bowel syndrome is not superior to placebo.
    Ziegenhagen DJ, Kruis W.
    J Gastroenterol Hepatol; 2004 Jul 15; 19(7):744-9. PubMed ID: 15209619
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.